文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

透析前慢性肾脏病患者骨质疏松的危险因素及临床预测模型。

Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.

机构信息

Nephrology Department, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.

Nuclear Medicine, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.

出版信息

Ren Fail. 2024 Dec;46(2):2361802. doi: 10.1080/0886022X.2024.2361802. Epub 2024 Jun 14.


DOI:10.1080/0886022X.2024.2361802
PMID:38874080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182074/
Abstract

BACKGROUND: Osteoporosis in pre-dialysis chronic kidney disease (CKD) patients has been overlooked, and the risk factors of osteoporosis in these patients have not been adequately studied. OBJECTIVE: To identify risk factors for osteoporosis in pre-dialysis CKD patients and develop predictive models to estimate the likelihood of osteoporosis. METHODS: Dual-energy X-ray absorptiometry was used to measure bone mineral density, and clinical examination results were collected from 326 pre-dialysis CKD patients. Binary logistic regression was employed to explore the risk factors associated with osteoporosis and develop predictive models. RESULTS: In this cohort, 53.4% ( = 174) were male, 46.6% ( = 152) were female, and 21.8% ( = 71) were diagnosed with osteoporosis. Among those diagnosed with osteoporosis, 67.6% ( = 48) were female and 32.4% ( = 23) were male. Older age and low 25-(OH)-Vitamin D levels were identified as risk factors for osteoporosis in males. For females, older age, being underweight, higher bone alkaline phosphatase (NBAP), and advanced CKD (G5) were significant risk factors, while higher iPTH was protective. Older age, being underweight, and higher NBAP were risk factors for osteoporosis in the G1-4 subgroup. In the G5 subgroup, older age and higher NBAP increased the risk, while high 25-(OH)-Vitamin D or iPTH had protective effects. Nomogram models were developed to assess osteoporosis risk in pre-dialysis patients based on gender and renal function stage. CONCLUSION: Risk factors for osteoporosis vary by gender and renal function stages. The nomogram clinical prediction models we constructed may aid in the rapid screening of patients at high risk of osteoporosis.

摘要

背景: 透析前慢性肾脏病(CKD)患者的骨质疏松症一直被忽视,这些患者的骨质疏松症危险因素尚未得到充分研究。

目的: 确定透析前 CKD 患者骨质疏松症的危险因素,并建立预测模型来估计骨质疏松症的可能性。

方法: 使用双能 X 射线吸收法测量骨矿物质密度,并从 326 名透析前 CKD 患者中收集临床检查结果。采用二元逻辑回归分析探讨与骨质疏松症相关的危险因素,并建立预测模型。

结果: 在该队列中,53.4%( = 174)为男性,46.6%( = 152)为女性,21.8%( = 71)被诊断为骨质疏松症。在诊断为骨质疏松症的患者中,67.6%( = 48)为女性,32.4%( = 23)为男性。年龄较大和 25-(OH)-维生素 D 水平较低被确定为男性骨质疏松症的危险因素。对于女性,年龄较大、体重不足、骨碱性磷酸酶(NBAP)较高和 CKD 进展(G5)是显著的危险因素,而较高的 iPTH 则具有保护作用。年龄较大、体重不足和 NBAP 较高是 G1-4 亚组骨质疏松症的危险因素。在 G5 亚组中,年龄较大和 NBAP 较高增加了风险,而较高的 25-(OH)-维生素 D 或 iPTH 具有保护作用。我们基于性别和肾功能分期开发了诺莫图模型来评估透析前患者的骨质疏松症风险。

结论: 骨质疏松症的危险因素因性别和肾功能分期而异。我们构建的诺莫图临床预测模型可能有助于快速筛选骨质疏松症高危患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/5cf01c6034a2/IRNF_A_2361802_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/5cf01c6034a2/IRNF_A_2361802_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204a/11182074/f347f58755eb/IRNF_A_2361802_F0002_C.jpg

相似文献

[1]
Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.

Ren Fail. 2024-12

[2]
Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.

Diabetes Metab Syndr. 2017-12

[3]
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].

Wien Med Wochenschr. 2023-10

[4]
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.

Clin J Am Soc Nephrol. 2014-7

[5]
Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.

Osteoporos Int. 2017-10-9

[6]
Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.

Osteoporos Int. 2020-12

[7]
High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis.

Clin Nephrol. 2004-12

[8]
Bone mineral density in patients with predialysis chronic kidney disease.

Ren Fail. 2013-7-23

[9]
Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.

Am J Kidney Dis. 2022-3

[10]
Chronic kidney disease is associated with low BMD at the hip but not at the spine.

Osteoporos Int. 2019-1-28

引用本文的文献

[1]
Subgroup-Specific Osteoporosis Risk in Chronic Kidney Disease: Insights from a Nationwide Korean Cohort.

Biomedicines. 2025-8-11

[2]
Machine learning models to predict osteoporosis in patients with chronic kidney disease stage 3-5 and end-stage kidney disease.

Sci Rep. 2025-4-3

[3]
The Management of Osteoporosis in Chronic Kidney Disease: A Review of Diagnostic and Therapeutic Approaches.

Cureus. 2024-11-17

[4]
Individualizing the lifesaving journey for calciphylaxis: addressing rapidly progressive attacks with multidimensional and AI research for regenerative medicine.

Ren Fail. 2024-12

本文引用的文献

[1]
Establishing age-adjusted trabecular bone score curves using dual-energy X-ray absorptiometry in Chinese women and men: a cross-sectional study.

Quant Imaging Med Surg. 2023-4-1

[2]
Management of osteoporosis in patients with chronic kidney disease.

Osteoporos Int. 2022-11

[3]
Early Menopause May Associate With a Higher Risk of CKD and All-Cause Mortality in Postmenopausal Women: An Analysis of NHANES, 1999-2014.

Front Med (Lausanne). 2022-3-18

[4]
High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women.

Front Endocrinol (Lausanne). 2021

[5]
American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update.

Endocr Pract. 2021-4

[6]
Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a-G5D: A Systematic Review and Meta-analysis.

Am J Kidney Dis. 2020-7-9

[7]
Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.

Osteoporos Int. 2020-12

[8]
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.

Endocr Pract. 2020-5

[9]
The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.

Osteoporos Int. 2020-3

[10]
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Kidney Int Suppl (2011). 2017-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索